Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 780 | 910 | 1,260 | 600 | 880 |
| Cost of Goods | 530 | 460 | 420 | 260 | 270 |
| Gross Profit | 240 | 440 | 840 | 340 | 610 |
| Operating Expenses | 1,920 | 1,840 | 1,170 | 750 | 960 |
| Operating Income | -1,140 | -930 | 90 | -150 | -80 |
| Interest Expense | 10 | 1 | 0 | 0 | 0 |
| Other Income | 80 | 91 | 0 | 0 | 0 |
| Pre-tax Income | -1,070 | -840 | 90 | -150 | -80 |
| Net Income Continuous | -1,070 | -840 | 90 | -150 | -80 |
| Net Income | $-1,070 | $-840 | $-660 | $-920 | $-810 |
| EBITDA(a) | $-1,030 | $-830 | $90 | $-150 | $-80 |